MDT up +1.09% percent Today $MDT High is at 69.32
Post# of 99
Posted On: 11/13/2014 1:33:24 PM
MDT up +1.09% percent Today $MDT High is at 69.32 and the Low 68.66 with current volume of 1,388,538.
Recent News posted below.
Medtronic Inc MDT other info.
http://investorshangout.com/Medtronic-Inc-MDT-51763/
MDT Medtronic Inc Recent Headline News
Midday Glance: Medical Devices companies
AP - 4 mins ago
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
ZMH: 110.56 (-0.31), JNJ: 108.72 (-0.03), MDT: 69.24 (+0.74), BAX: 72.11 (+0.78)
Agilent 2.0: Phase 2 Of Corporate Action?
AtonRa Partners - at Seeking Alpha - 12 mins ago
MDT: 69.24 (+0.74), A: 41.36 (-0.09), TMO: 118.09 (-0.42), DHR: 82.09 (-0.27)
Early Glance: Medical Devices companies
AP - 1 hr 16 mins ago
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
ZMH: 110.56 (-0.31), JNJ: 108.72 (-0.03), MDT: 69.24 (+0.74), BAX: 72.11 (+0.78)
Global Insulin Delivery Devices Market Outlook 2018
M2 - Thu Nov 13, 4:59AM CST
Research and Markets (http://www.researchandmarkets.com/research/ttg7ws/global_insulin) has announced the addition of the "Global Insulin Delivery Devices Market Outlook 2018" report to their offering. In 2013, a total of 382 Million People had diabetes and by 2030 this number is expected to rise to 552 Million. This finding by the International Diabetes Federation (IDF) and similar results from studies done by organizations of repute such as WHO, CDC, NHS, etc., suggest that a huge patient population exists in the diabetes market. In 2013, health expenditure on diabetes accounted for around 10% of the total health expenditure globally. Of all the market segments that result from this multibillion dollar expenditure, insulin delivery devices represents one of the most rapidly expanding areas and is thus the key focus of this current study. In this latest research study Global Insulin Delivery Devices Market Outlook 2018, the analysts identified the market dynamics in various important regions to highlight the areas offering promising opportunities to companies for boosting their growth. Insulin delivery devices predominantly include Insulin Syringes, Insulin Pens (Disposable and Reusable), Insulin Pumps and Insulin Jet Injectors. Our study provides a comprehensive analysis of the delivery devices market, both at global and regional levels. This analysis includes the current market statistics, key drivers stimulating each segment's growth, and the future outlook of the segments. Key Topics Covered: 1. Analyst View 2. Research Methodology 3. Global Insulin Market Overview to 2018 4. Industry Trends and Drivers 5. Key Market Restraints 6. Global Insulin Delivery Devices Market Outlook to 2018 7. Insulin Delivery Devices: Current and Future Outlook to 2018 8. Emerging Devices 9. Key Players Companies Mentioned: - Abbott Laboratories - B. Braun Melsungen AG - Becton Dickinson - Eli Lilly - F. Hoffmann La Roche - Insulet Corporation - Johnson and Johnson - Medtronic - Novo Nordisk - Sanofi-Aventis - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/tt...al_insulin
JNJ: 108.72 (-0.03), ABT: 44.42 (+0.19), PODD: 46.08 (-0.32), NVO: 43.95 (-0.37), MDT: 69.24 (+0.74), LLY: 67.66 (+0.26)
Neurostimulation Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Competitive Scenario And Forecasts, 2012 To 2020
M2 - Thu Nov 13, 2:52AM CST
Industry Insights
BSX: 13.37 (-0.04), MDT: 69.24 (+0.74), CYBX: 51.47 (+0.95)
Final Glance: Medical Devices companies
AP - Wed Nov 12, 5:02PM CST
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
ZMH: 110.56 (-0.31), JNJ: 108.72 (-0.03), MDT: 69.24 (+0.74), BAX: 72.11 (+0.78)
Medtronic Adds to Endurant 'AAA' Stent Graft System
Thomson Reuters ONE - Wed Nov 12, 2:00PM CST
New Bifurcated Component Leverages Proven Design of Predicate Device and Expands Anatomical Customization Options for Endovascular Repair of Abdominal Aortic Aneurysms
MDT: 69.24 (+0.74)
Medtronic and St. Jude Medical Dominate the European Pain Management Device Market
PR Newswire - Wed Nov 12, 11:00AM CST
Decision Resources Group finds that the European pain management device market generates a majority of revenue from select products, such as spinal cord stimulation (SCS) and radiofrequency (RF) ablation devices. This results in key players like Medtronic and St. Jude Medical capturing significant share. Increasing recognition of the value of pain management devices over pharmaceuticals will, however, drive moderate market growth, leading to increased competition as manufacturers shift focus to the device market.
MDT: 69.24 (+0.74)
Global Orthopedic Implant Physician Preference Survey 2015 - Executive Summary
M2 - Wed Nov 12, 9:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/wkgmtc/global_orthopedic) has announced the addition of the "Global Orthopedic Implant Physician Preference Survey 2015 (Executive Summary)" report to their offering. This survey asked physicians to choose the company or companies that provide knee repair products with which they are most satisfied. More than one-third of respondents who do knee repair surgeries included DePuy Synthes as one of their preferred companies. This was followed closely by other competitors such as MAKO Surgical, Smith & Nephew, Stryker and Zimmer. The survey also asked physicians to suggest what factor or factors would most likely trigger them to switch over to using a different knee repair product from that which they were currently most comfortable. While many surgeons suggested multiple factors, one that appeared most frequently was if another product was able to demonstrate better clinical efficacy in comparison to the current product in use. This trend was present from respondents across all geographical regions and clinical settings. Despite subtle differences in physician product preference across the various regions, the survey results suggest that DePuy Synthes is the most highly preferred supplier of knee repair products globally. Key Topics Covered: - Survey Background - Survey Respondent Profile - Knee Repair Products - Foot Digit Repair Products - Hip Repair Products - Hand Digit Repair Products - Spinal Surgery Products - Custom Implants Companies Mentioned - Aesculap - Alphatec Spine - Arthrex - BioPro - Biomet - DJO Surgical - DePuy Synthes - Exactech - Globus Medical - Integra LifeSciences - K2M - MAKO Surgical - Medtronic - NuVasive - Small Bone Innovations (SBi) - Smith & Nephew - Stryker - Wright Medical - Zimmer For more information visit http://www.researchandmarkets.com/research/wk...orthopedic
SNN: 33.59 (+0.06), MDT: 69.24 (+0.74), GMED: 23.01 (-0.15)
Global Orthopedic Implant Physician Preference Survey 2015
M2 - Wed Nov 12, 9:04AM CST
Research and Markets (http://www.researchandmarkets.com/research/9rfcq6/global_orthopedic) has announced the addition of the "Global Orthopedic Implant Physician Preference Survey 2015" report to their offering. This survey asked physicians to choose the company or companies that provide knee repair products with which they are most satisfied. More than one-third of respondents who do knee repair surgeries included DePuy Synthes as one of their preferred companies. This was followed closely by other competitors such as MAKO Surgical, Smith & Nephew, Stryker and Zimmer. The survey also asked physicians to suggest what factor or factors would most likely trigger them to switch over to using a different knee repair product from that which they were currently most comfortable. While many surgeons suggested multiple factors, one that appeared most frequently was if another product was able to demonstrate better clinical efficacy in comparison to the current product in use. This trend was present from respondents across all geographical regions and clinical settings. Despite subtle differences in physician product preference across the various regions, the survey results suggest that DePuy Synthes is the most highly preferred supplier of knee repair products globally. Survey includes: - Patient Volumes - Procedures Performed - Clinical Setting - Product prerference by manufacturer - Factors influencing produt change - Preferences by region, country and clinical setting Key Topics Covered: 1. Executive Summary 2. Research Methodology And Survey Coverage 3. Survey Respondent Profile 4. Osteoarthritis Treatment Preferences 5. Product Preference Overview 6. Knee Repair Products 7. Hip Repair Products 8. Hand Digit Repair Products 9. Foot Digit Repair Products 10. Cervical Interbody Products 11. Thoracolumbar Interbody Products 12. Custom Implants Companies Mentioned - Aesculap - Alphatec Spine - Arthrex - BioPro - Biomet - DJO Surgical - DePuy Synthes - Exactech - Globus Medical - Integra LifeSciences - K2M - MAKO Surgical - Medtronic - NuVasive - Small Bone Innovations (SBi) - Smith & Nephew - Stryker - Wright Medical - Zimmer For more information visit http://www.researchandmarkets.com/research/9r...orthopedic
SNN: 33.59 (+0.06), MDT: 69.24 (+0.74), GMED: 23.01 (-0.15)
Wall Street Breakfast: Global Banks Fined $3.4B In Forex Probe
Wall Street Breakfast - Seeking Alpha - Wed Nov 12, 5:30AM CST
Economy Japanese stocks scaled seven-year highs this morning on further speculation that Prime Minister Shinzo Abe will postpone a planned sales tax hike and call a general election for December. The Sankei newspaper reported that Abe would...
VRX: 131.32 (+0.23), MDT: 69.24 (+0.74), C: 53.19 (-0.23), WMT: 82.60 (+3.40), RBS: 11.73 (-0.09), UBS: 17.51 (+0.13), NOK: 8.23 (+0.18), YHOO: 50.51 (-0.09), PBR: 10.29 (-0.27), SPY: 203.84 (-0.12), SAP: 66.50 (+0.05), EBAY: 54.34 (+0.28), JPM: 60.20 (-0.36), BHP: 57.80 (-0.38), AAPL: 113.02 (+1.77), BCS: 14.41 (-0.17), FRM: 6.34 (-0.25), COV: 93.74 (+0.86), HSBC: 50.05 (-0.17), FRGI: 56.42 (-0.25), ZTS: 43.02 (+0.38), DLA: 10.45 (-0.10), QQQ: 102.87 (+0.41), AOL: 46.46 (+0.62), BABA: 115.92 (-2.28)
Medtronic submits concessions for $43B Covidien takeover
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 3:53AM CST
MDT: 69.24 (+0.74), COV: 93.74 (+0.86)
Three Medtronic Infuse Personal Injury Cases Remanded to Circuit Court, Parker Waichman LLP Announces
PRWeb - Tue Nov 11, 2:30PM CST
Parker Waichman LLP, a national law firm that has long been dedicated to protecting the rights of victims who have been injured during medical procedures and by medical devices, comments on a Court ruling in which three lawsuit filed against Medtronic, Inc. will be remanded to the Circuit Court of the City of St. Louis for further proceedings. Parker Waichman LLP is collaborating on these cases with Neblett Beard & Arsneault and The Drakulich Firm.
MDT: 69.24 (+0.74)
DexCom Scales 52-Week High on Product Pipeline Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 1:10PM CST
Impressive third-quarter 2014 results, recent FDA approvals for its new products along with a robust product pipeline contribute to the growth trajectory of DexCom, Inc. (DXCM), creating good momentum for 2015 as well.
ABT: 44.42 (+0.19), JNJ: 108.71 (-0.04), DXCM: 53.83 (-0.18), MDT: 69.24 (+0.74)
Mid-Term Election Impacts On The Market Revisited
Bret Jensen - at Seeking Alpha - Tue Nov 11, 10:27AM CST
SPY: 203.84 (-0.12), QQQ: 102.87 (+0.41), MDT: 69.24 (+0.74), IEF: 104.77 (+0.06), DIA: 176.26 (+0.22), STJ: 65.58 (-0.10), IWM: 117.17 (-0.73), TLT: 118.65 (+0.02)
Medtronic (MDT) Breaks Through Resistance at $69.08
Comtex SmarTrend(R) - Tue Nov 11, 10:14AM CST
Shares of Medtronic (NYSE:MDT) opened today above their pivot of $68.38 and have already reached the first level of resistance at $69.08. Should the shares continue to rise, the resistance pivots of $69.44 and $70.50 will be of interest.
MDT: 69.24 (+0.74)
Recent News posted below.
Medtronic Inc MDT other info.
http://investorshangout.com/Medtronic-Inc-MDT-51763/
MDT Medtronic Inc Recent Headline News
Midday Glance: Medical Devices companies
AP - 4 mins ago
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
ZMH: 110.56 (-0.31), JNJ: 108.72 (-0.03), MDT: 69.24 (+0.74), BAX: 72.11 (+0.78)
Agilent 2.0: Phase 2 Of Corporate Action?
AtonRa Partners - at Seeking Alpha - 12 mins ago
MDT: 69.24 (+0.74), A: 41.36 (-0.09), TMO: 118.09 (-0.42), DHR: 82.09 (-0.27)
Early Glance: Medical Devices companies
AP - 1 hr 16 mins ago
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
ZMH: 110.56 (-0.31), JNJ: 108.72 (-0.03), MDT: 69.24 (+0.74), BAX: 72.11 (+0.78)
Global Insulin Delivery Devices Market Outlook 2018
M2 - Thu Nov 13, 4:59AM CST
Research and Markets (http://www.researchandmarkets.com/research/ttg7ws/global_insulin) has announced the addition of the "Global Insulin Delivery Devices Market Outlook 2018" report to their offering. In 2013, a total of 382 Million People had diabetes and by 2030 this number is expected to rise to 552 Million. This finding by the International Diabetes Federation (IDF) and similar results from studies done by organizations of repute such as WHO, CDC, NHS, etc., suggest that a huge patient population exists in the diabetes market. In 2013, health expenditure on diabetes accounted for around 10% of the total health expenditure globally. Of all the market segments that result from this multibillion dollar expenditure, insulin delivery devices represents one of the most rapidly expanding areas and is thus the key focus of this current study. In this latest research study Global Insulin Delivery Devices Market Outlook 2018, the analysts identified the market dynamics in various important regions to highlight the areas offering promising opportunities to companies for boosting their growth. Insulin delivery devices predominantly include Insulin Syringes, Insulin Pens (Disposable and Reusable), Insulin Pumps and Insulin Jet Injectors. Our study provides a comprehensive analysis of the delivery devices market, both at global and regional levels. This analysis includes the current market statistics, key drivers stimulating each segment's growth, and the future outlook of the segments. Key Topics Covered: 1. Analyst View 2. Research Methodology 3. Global Insulin Market Overview to 2018 4. Industry Trends and Drivers 5. Key Market Restraints 6. Global Insulin Delivery Devices Market Outlook to 2018 7. Insulin Delivery Devices: Current and Future Outlook to 2018 8. Emerging Devices 9. Key Players Companies Mentioned: - Abbott Laboratories - B. Braun Melsungen AG - Becton Dickinson - Eli Lilly - F. Hoffmann La Roche - Insulet Corporation - Johnson and Johnson - Medtronic - Novo Nordisk - Sanofi-Aventis - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/tt...al_insulin
JNJ: 108.72 (-0.03), ABT: 44.42 (+0.19), PODD: 46.08 (-0.32), NVO: 43.95 (-0.37), MDT: 69.24 (+0.74), LLY: 67.66 (+0.26)
Neurostimulation Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Competitive Scenario And Forecasts, 2012 To 2020
M2 - Thu Nov 13, 2:52AM CST
Industry Insights
BSX: 13.37 (-0.04), MDT: 69.24 (+0.74), CYBX: 51.47 (+0.95)
Final Glance: Medical Devices companies
AP - Wed Nov 12, 5:02PM CST
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
ZMH: 110.56 (-0.31), JNJ: 108.72 (-0.03), MDT: 69.24 (+0.74), BAX: 72.11 (+0.78)
Medtronic Adds to Endurant 'AAA' Stent Graft System
Thomson Reuters ONE - Wed Nov 12, 2:00PM CST
New Bifurcated Component Leverages Proven Design of Predicate Device and Expands Anatomical Customization Options for Endovascular Repair of Abdominal Aortic Aneurysms
MDT: 69.24 (+0.74)
Medtronic and St. Jude Medical Dominate the European Pain Management Device Market
PR Newswire - Wed Nov 12, 11:00AM CST
Decision Resources Group finds that the European pain management device market generates a majority of revenue from select products, such as spinal cord stimulation (SCS) and radiofrequency (RF) ablation devices. This results in key players like Medtronic and St. Jude Medical capturing significant share. Increasing recognition of the value of pain management devices over pharmaceuticals will, however, drive moderate market growth, leading to increased competition as manufacturers shift focus to the device market.
MDT: 69.24 (+0.74)
Global Orthopedic Implant Physician Preference Survey 2015 - Executive Summary
M2 - Wed Nov 12, 9:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/wkgmtc/global_orthopedic) has announced the addition of the "Global Orthopedic Implant Physician Preference Survey 2015 (Executive Summary)" report to their offering. This survey asked physicians to choose the company or companies that provide knee repair products with which they are most satisfied. More than one-third of respondents who do knee repair surgeries included DePuy Synthes as one of their preferred companies. This was followed closely by other competitors such as MAKO Surgical, Smith & Nephew, Stryker and Zimmer. The survey also asked physicians to suggest what factor or factors would most likely trigger them to switch over to using a different knee repair product from that which they were currently most comfortable. While many surgeons suggested multiple factors, one that appeared most frequently was if another product was able to demonstrate better clinical efficacy in comparison to the current product in use. This trend was present from respondents across all geographical regions and clinical settings. Despite subtle differences in physician product preference across the various regions, the survey results suggest that DePuy Synthes is the most highly preferred supplier of knee repair products globally. Key Topics Covered: - Survey Background - Survey Respondent Profile - Knee Repair Products - Foot Digit Repair Products - Hip Repair Products - Hand Digit Repair Products - Spinal Surgery Products - Custom Implants Companies Mentioned - Aesculap - Alphatec Spine - Arthrex - BioPro - Biomet - DJO Surgical - DePuy Synthes - Exactech - Globus Medical - Integra LifeSciences - K2M - MAKO Surgical - Medtronic - NuVasive - Small Bone Innovations (SBi) - Smith & Nephew - Stryker - Wright Medical - Zimmer For more information visit http://www.researchandmarkets.com/research/wk...orthopedic
SNN: 33.59 (+0.06), MDT: 69.24 (+0.74), GMED: 23.01 (-0.15)
Global Orthopedic Implant Physician Preference Survey 2015
M2 - Wed Nov 12, 9:04AM CST
Research and Markets (http://www.researchandmarkets.com/research/9rfcq6/global_orthopedic) has announced the addition of the "Global Orthopedic Implant Physician Preference Survey 2015" report to their offering. This survey asked physicians to choose the company or companies that provide knee repair products with which they are most satisfied. More than one-third of respondents who do knee repair surgeries included DePuy Synthes as one of their preferred companies. This was followed closely by other competitors such as MAKO Surgical, Smith & Nephew, Stryker and Zimmer. The survey also asked physicians to suggest what factor or factors would most likely trigger them to switch over to using a different knee repair product from that which they were currently most comfortable. While many surgeons suggested multiple factors, one that appeared most frequently was if another product was able to demonstrate better clinical efficacy in comparison to the current product in use. This trend was present from respondents across all geographical regions and clinical settings. Despite subtle differences in physician product preference across the various regions, the survey results suggest that DePuy Synthes is the most highly preferred supplier of knee repair products globally. Survey includes: - Patient Volumes - Procedures Performed - Clinical Setting - Product prerference by manufacturer - Factors influencing produt change - Preferences by region, country and clinical setting Key Topics Covered: 1. Executive Summary 2. Research Methodology And Survey Coverage 3. Survey Respondent Profile 4. Osteoarthritis Treatment Preferences 5. Product Preference Overview 6. Knee Repair Products 7. Hip Repair Products 8. Hand Digit Repair Products 9. Foot Digit Repair Products 10. Cervical Interbody Products 11. Thoracolumbar Interbody Products 12. Custom Implants Companies Mentioned - Aesculap - Alphatec Spine - Arthrex - BioPro - Biomet - DJO Surgical - DePuy Synthes - Exactech - Globus Medical - Integra LifeSciences - K2M - MAKO Surgical - Medtronic - NuVasive - Small Bone Innovations (SBi) - Smith & Nephew - Stryker - Wright Medical - Zimmer For more information visit http://www.researchandmarkets.com/research/9r...orthopedic
SNN: 33.59 (+0.06), MDT: 69.24 (+0.74), GMED: 23.01 (-0.15)
Wall Street Breakfast: Global Banks Fined $3.4B In Forex Probe
Wall Street Breakfast - Seeking Alpha - Wed Nov 12, 5:30AM CST
Economy Japanese stocks scaled seven-year highs this morning on further speculation that Prime Minister Shinzo Abe will postpone a planned sales tax hike and call a general election for December. The Sankei newspaper reported that Abe would...
VRX: 131.32 (+0.23), MDT: 69.24 (+0.74), C: 53.19 (-0.23), WMT: 82.60 (+3.40), RBS: 11.73 (-0.09), UBS: 17.51 (+0.13), NOK: 8.23 (+0.18), YHOO: 50.51 (-0.09), PBR: 10.29 (-0.27), SPY: 203.84 (-0.12), SAP: 66.50 (+0.05), EBAY: 54.34 (+0.28), JPM: 60.20 (-0.36), BHP: 57.80 (-0.38), AAPL: 113.02 (+1.77), BCS: 14.41 (-0.17), FRM: 6.34 (-0.25), COV: 93.74 (+0.86), HSBC: 50.05 (-0.17), FRGI: 56.42 (-0.25), ZTS: 43.02 (+0.38), DLA: 10.45 (-0.10), QQQ: 102.87 (+0.41), AOL: 46.46 (+0.62), BABA: 115.92 (-2.28)
Medtronic submits concessions for $43B Covidien takeover
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 3:53AM CST
MDT: 69.24 (+0.74), COV: 93.74 (+0.86)
Three Medtronic Infuse Personal Injury Cases Remanded to Circuit Court, Parker Waichman LLP Announces
PRWeb - Tue Nov 11, 2:30PM CST
Parker Waichman LLP, a national law firm that has long been dedicated to protecting the rights of victims who have been injured during medical procedures and by medical devices, comments on a Court ruling in which three lawsuit filed against Medtronic, Inc. will be remanded to the Circuit Court of the City of St. Louis for further proceedings. Parker Waichman LLP is collaborating on these cases with Neblett Beard & Arsneault and The Drakulich Firm.
MDT: 69.24 (+0.74)
DexCom Scales 52-Week High on Product Pipeline Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 1:10PM CST
Impressive third-quarter 2014 results, recent FDA approvals for its new products along with a robust product pipeline contribute to the growth trajectory of DexCom, Inc. (DXCM), creating good momentum for 2015 as well.
ABT: 44.42 (+0.19), JNJ: 108.71 (-0.04), DXCM: 53.83 (-0.18), MDT: 69.24 (+0.74)
Mid-Term Election Impacts On The Market Revisited
Bret Jensen - at Seeking Alpha - Tue Nov 11, 10:27AM CST
SPY: 203.84 (-0.12), QQQ: 102.87 (+0.41), MDT: 69.24 (+0.74), IEF: 104.77 (+0.06), DIA: 176.26 (+0.22), STJ: 65.58 (-0.10), IWM: 117.17 (-0.73), TLT: 118.65 (+0.02)
Medtronic (MDT) Breaks Through Resistance at $69.08
Comtex SmarTrend(R) - Tue Nov 11, 10:14AM CST
Shares of Medtronic (NYSE:MDT) opened today above their pivot of $68.38 and have already reached the first level of resistance at $69.08. Should the shares continue to rise, the resistance pivots of $69.44 and $70.50 will be of interest.
MDT: 69.24 (+0.74)
(0)
(0)Medtronic, Inc. (MDT) Stock Research Links
Scroll down for more posts ▼